Dr. Hangyi Yan

Dr. Hangyi Yan

Scientific Review Officer



Biography

Division:
Division of Basic and Integrative Biological Sciences DTCS
Review Branch:
Respiratory, Cardiac, and Circulatory Sciences RCCS

Dr. Yan received her Ph.D. in biology from Johns Hopkins University. Her dissertation research at the National Cancer Institute (NCI) focused on immuno-oncology to understand how host immunity affects metastasis. For her post-doctoral training at the Food and Drug Administration (FDA), Dr. Yan established humanized mouse models to predict immunotoxicity of biologics. Prior to joining CSR, Dr. Yan was a policy analyst with a focus on device determination and device classification at the Center for Devices and Radiological Health (CDRH), FDA. She also served as a scientific reviewer for hematology in vitro diagnostic medical devices at CDRH/FDA.

 

Last updated: 04/11/2025 15:59